Aurora Cannabis Inc. (NYSE: ACB) announced on December 6th that the company, through its subsidiary Aurora Europe GmbH, has been selected to supply the country of Luxembourg with an initial 20kg shipment of medical cannabis to Division de la Pharmacie et des Medicaments.
The company was specifically selected to supply the country by the Luxembourg Health Ministry and was issued all of the necessary import and export licenses.
Chief Global Business Development Officer of Aurora Cannabis, Neil Belot, said, “To our knowledge, Aurora is the first medical cannabis producer selected by the Luxembourg Health Ministry to supply dried cannabis flower.”
Aurora’s initial supply commitment of 20kg is the Luxembourg Health Ministry’s first order of medical cannabis and is Aurora’s second medical cannabis order from a European government.
The company completed its first medical cannabis export and import for a European government in April of this year. 100kg of medical cannabis was received by the Italian government through the Italian Ministry of Defense and was distributed to Italian Pharmacies.
Risk of Prosecution for Marijuana-Related Companies. If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution. The Department of Treasury recently issued guidance noting: “[T]he Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana. Many states impose and enforce similar prohibitions. Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”